These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 38617169)

  • 1.
    Qian LD; Zhou ZA; Li SQ; Liu J; Zhang SX; Ren JL; Wang W; Yang J
    Quant Imaging Med Surg; 2024 Apr; 14(4):3131-3145. PubMed ID: 38617169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting MYCN amplification in paediatric neuroblastoma: development and validation of a 18F-FDG PET/CT-based radiomics signature.
    Qian LD; Zhang SX; Li SQ; Feng LJ; Zhou ZA; Liu J; Zhang MY; Yang JG
    Insights Imaging; 2023 Nov; 14(1):205. PubMed ID: 38001240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive value of 2-deoxy-2-fluorine-18-fluoro-D-glucose positron emission tomography/computed tomography parameters for MYCN amplification in high-risk neuroblastoma.
    Li S; Liu J; Wang G; Feng L; Yang X; Kan Y; Wang W; Yang J
    Eur J Radiol; 2024 Jan; 170():111243. PubMed ID: 38043380
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Qian LD; Feng LJ; Zhang SX; Liu J; Ren JL; Liu L; Zhang H; Yang J
    Quant Imaging Med Surg; 2023 Jan; 13(1):94-107. PubMed ID: 36620179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of MYCN Amplification, 1p and 11q Aberrations in Pediatric Neuroblastoma
    Qian L; Yang S; Zhang S; Qin H; Wang W; Kan Y; Liu L; Li J; Zhang H; Yang J
    Front Med (Lausanne); 2022; 9():840777. PubMed ID: 35372427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical parameters combined with radiomics features of PET/CT can predict recurrence in patients with high-risk pediatric neuroblastoma.
    Feng L; Qian L; Yang S; Ren Q; Zhang S; Qin H; Wang W; Wang C; Zhang H; Yang J
    BMC Med Imaging; 2022 May; 22(1):102. PubMed ID: 35643445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiogenomics of neuroblastoma in pediatric patients: CT-based radiomics signature in predicting MYCN amplification.
    Wu H; Wu C; Zheng H; Wang L; Guan W; Duan S; Wang D
    Eur Radiol; 2021 May; 31(5):3080-3089. PubMed ID: 33118047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic Value of
    Feng L; Yang X; Lu X; Kan Y; Wang C; Zhang H; Wang W; Yang J
    Acad Radiol; 2023 May; 30(5):940-951. PubMed ID: 36117128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CT-Based Radiomics Signature With Machine Learning Predicts MYCN Amplification in Pediatric Abdominal Neuroblastoma.
    Chen X; Wang H; Huang K; Liu H; Ding H; Zhang L; Zhang T; Yu W; He L
    Front Oncol; 2021; 11():687884. PubMed ID: 34109133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differentiation of early relapse and late relapse in intermediate- and high-risk neuroblastoma with an
    Feng L; Yao X; Lu X; Wang C; Wang W; Yang J
    Abdom Radiol (NY); 2024 Mar; 49(3):888-899. PubMed ID: 38315193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and validation of a
    Liu H; Cui Y; Chang C; Zhou Z; Zhang Y; Ma C; Yin Y; Wang R
    BMC Cancer; 2024 Jan; 24(1):150. PubMed ID: 38291351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting PD-L1 expression status in patients with non-small cell lung cancer using [
    Zhao X; Zhao Y; Zhang J; Zhang Z; Liu L; Zhao X
    EJNMMI Res; 2023 Jan; 13(1):4. PubMed ID: 36682020
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Hu S; Kang Y; Xie Y; Yang T; Yang Y; Jiao J; Zou Q; Zhang H; Zhang Y
    Abdom Radiol (NY); 2023 Feb; 48(2):532-542. PubMed ID: 36370179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Value of pre-therapy
    Zhang J; Zhao X; Zhao Y; Zhang J; Zhang Z; Wang J; Wang Y; Dai M; Han J
    Eur J Nucl Med Mol Imaging; 2020 May; 47(5):1137-1146. PubMed ID: 31728587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Graph Neural Network Model for Prediction of Non-Small Cell Lung Cancer Lymph Node Metastasis Using Protein-Protein Interaction Network and
    Ju H; Kim K; Kim BI; Woo SK
    Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38255770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Novel Approach Using FDG-PET/CT-Based Radiomics to Assess Tumor Immune Phenotypes in Patients With Non-Small Cell Lung Cancer.
    Zhou J; Zou S; Kuang D; Yan J; Zhao J; Zhu X
    Front Oncol; 2021; 11():769272. PubMed ID: 34868999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Value of
    Wang N; Dai M; Jing F; Liu Y; Zhao Y; Zhang Z; Wang J; Zhang J; Wang Y; Zhao X
    Int J Radiat Biol; 2024 Sep; ():1-9. PubMed ID: 39288285
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Feng L; Yang X; Lu X; Kan Y; Wang C; Sun D; Zhang H; Wang W; Yang J
    Insights Imaging; 2022 Sep; 13(1):144. PubMed ID: 36057694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrated CT Radiomics Features Could Enhance the Efficacy of
    Zhou W; Huang Q; Wen J; Li M; Zhu Y; Liu Y; Dai Y; Guan Y; Zhou Z; Hua T
    Front Oncol; 2021; 11():772703. PubMed ID: 34869011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular subtype classification of breast cancer using established radiomic signature models based on
    Liu J; Bian H; Zhang Y; Gao Y; Yin G; Wang Z; Li X; Ma W; Xu W
    Front Biosci (Landmark Ed); 2021 Aug; 26(9):475-484. PubMed ID: 34590460
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.